<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8">
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <title>Hyperacusis Guide - Botox</title>
  <link rel="stylesheet" href="styles.css">
  <link rel="stylesheet" href="styles.css">
  <link rel="preconnect" href="https://fonts.googleapis.com">
  <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
  <link href="https://fonts.googleapis.com/css2?family=Montserrat:ital,wght@0,100..900;1,100..900&display=swap" rel="stylesheet">
  <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.5.0/css/all.min.css">
</head>
<body>
  <header>
    <h1 class="logo">
    <i class="fa fa-compass"></i>
    Hyperacusis Guide</h1>
    <button id="hamburger">&#9776;</button>
  </header>

  <nav id="sidebar">
    <ul>
      <li><a href="index.html">Precautionary Guide</a></li>
      <li><a href="hyperacusis.html">Hyperacusis & Noxacusis</a></li>
      <li><a href="mem.html">MEM & TTTS</a></li>
      <li><a href="imaging.html">Diagnostic Imaging</a></li>
      <li><a href="medications.html">Medications</a></li>
      <li><a href="silverstein.html">Silverstein Procedure</a></li>
      <li><a href="botox.html">Botox</a></li>
      <li><a href="patch.html">Paper Patching</a></li>
      <li><a href="spreadsheets.html">Treatment Spreadsheets</a></li> 
      <li><a href="anatomy.html">Middle Ear Anatomy</a></li>
      <li><a href="community.html">Community & Resources</a></li> 
      <li><a href="contact.html">Contact</a></li> 
      <li><a href="about.html">About</a></li>
    </ul>
  </nav>

  <main>
    <article>
      <h1>Botox</h1>

      <p>
        Botox (botulinum toxin type A) has been explored as a potential treatment for hyperacusis, middle ear myoclonus (MEM), 
        and tonic tensor tympani syndrome (TTTS) due to its ability to temporarily weaken overactive muscles involved in 
        abnormal sound perception or middle ear movement. 
      </p>
      <p>
        In cases of MEM or TTTS—conditions characterized by involuntary 
        contractions of the tensor tympani or stapedius muscles—botox injections have been used to reduce muscle hyperactivity 
        and relieve the associated fluttering, thumping, or pressure sensations in the ear. The toxin is typically injected 
        through the tympanic membrane or via a transcanal approach into the affected muscle under microscopic guidance. 
      </p>
      <p>
        In some reported cases, patients have experienced a significant reduction in middle ear spasms, sound sensitivity, 
        and pain following treatment, often lasting several months until the effects wear off.
      </p>

      <p>
        For hyperacusis, botox has also been used experimentally to dampen the acoustic reflex or decrease neural overactivity 
        contributing to loudness intolerance. While these findings are promising, evidence remains limited to small case reports 
        and pilot studies, and outcomes vary widely depending on injection technique and the underlying cause of the patient’s 
        symptoms. 
      </p>
      <p>
        Botox treatment for hyperacusis and MEM/TTTS is therefore considered experimental, but may represent a 
        valuable option for patients with refractory symptoms not responsive to medication or sound therapy.
      </p>
            <p>
      <a class="link" href="https://docs.google.com/spreadsheets/d/1-ePvJPk4BhBeoOBKPc1gmXriXd4TYD7Z8n3yyEMoy5I/edit?usp=sharing" target="_blank" rel="noopener noreferrer">Medication, Botox, and Paper Patching Spreadsheet</a>
      </P>
    </article>
  </main>
  
  <script src="script.js"></script>
</body>
</html>
